Primer: Scilex (SCLX US) - Aug 2026
Scilex is a commercial-stage pharmaceutical company focused on non-opioid pain management, a sector poised for growth due to the ongoing opioid...
92 Views
SPAC Talk: Upcoming Lock-Up Expirations May Need a Health Warning
KEY HIGHLIGHTS SPAC IPO activity is nothing to write home about, but it’s outpacing traditional IPOs. The SPAC IPO market continues to trundle...
807 Views
SCLX: 3Q Earnings Beat Estimates
SCLX is filling a much-needed area of the health care sector, that of developing non-opioid pain relief products. The company already has...
377 Views
SCLX: Deal Brings Huge Potential
SCLX is filling a much-needed area of the health care sector, that of developing non-opioid pain relief products. The company already has...
502 Views
SCLX: Financing Deal Puts Company in Good Shape
SCLX is filling a much-needed area of the health care sector, that of developing non-opioid pain relief products. The company already has...
360 Views